Cover Image
市場調查報告書

多烯磷脂酰胆碱的中國市場:2010-2019年

Investigation Report on China Polyene Phosphatidyl Choline Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 334094
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
多烯磷脂酰胆碱的中國市場:2010-2019年 Investigation Report on China Polyene Phosphatidyl Choline Market, 2010-2019
出版日期: 2015年07月02日 內容資訊: 英文 30 Pages
簡介

中國多烯磷脂酰胆碱市場自2006年之後開始加速,在治療肝病的輔助劑上佔了相當大的市佔率。調查對象醫院之多烯磷脂酰胆碱的銷售額從2005年不到6000萬人民幣,到2014年超過4億人民幣的規模,達成了25%CAGR的莫大成長。

本報告提供中國的多烯磷脂酰胆碱的市場相關調查,提供您多烯磷脂酰胆碱的功用·效果,中國市場中專利及核准狀況,銷售額·銷售量的變化與預測,價格趨勢,並彙整主要製造商與市場佔有率,競爭環境及其展望,主要製造商簡介等資料。

第1章 多烯磷脂酰胆碱的相關概念

  • 功用·效果
  • 全球市場的銷售情形

第2章 中國的多烯磷脂酰胆碱市場簡介

  • 專利·核準情況
  • 主要製造商
  • 市場規模

第3章 中國的多烯磷脂酰胆碱銷售情形

  • 銷售額
    • 整體
    • 各地區
  • 銷售量
    • 整體
    • 各地區

第4章 中國的多烯磷脂酰胆碱主要廠商的市場佔有率

  • 市場佔有率:銷售額
  • 市場佔有率:銷售量

第5章 中國的多烯磷脂酰胆碱的各劑型佔有率

  • 各種劑型的市場佔有率:銷售額
  • 各種劑型的市場佔有率:銷售量

第6章 中國的醫院的多烯磷脂酰胆碱參照價格

  • Aventis Pharma S.p.A.(SP) (商品名:Essentiale Forte)
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd (商品名:Yibisheng)
  • Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
  • Shenzhen Sanofi Pasteur Biological Products Co., Ltd (商品名:Essentiale Forte)

第7章 中國市場中多烯磷脂酰胆碱主要製造商

  • Shenzhen Sanofi Pasteur Biological Products Co., Ltd
  • Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd
  • Aventis Pharma S.p.A.

第8章 中國的多烯磷脂酰胆碱市場展望

  • 市場規模預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1507255

China is recognized worldwide as one of the countries with a high incidence of liver disease. Viral hepatitis, fatty liver, alcoholic liver disease, medicamentous liver lesion and liver cancer have posed a severe threat to Chinese people's health. In recent years, drugs for liver disease that rank second to proton pump inhibitor in drugs for digestive system have gradually become a variety with large sales value which occupies 30% of the total sales value of all ten categories of drugs for digestive system.

Among all the drugs for liver disease, polyene phosphatidyl choline is the natural diglyceride of cholinephosphoric acid and unsaturated fatty acids which can protect hepatocyte from lesion, alleviate inflammation reaction and improve the detoxification of the liver. And it is used for the treatment of hepatitis (acute and chronic), hepatic cirrhosis and poisoning with certain efficacy in the clinic. First developed by Sanofi, polyene phosphatidyl choline has been marketed under the trade name of Essentiale Forte.

Some local enterprises are already capable of producing polyene phosphatidyl choline APIs and injections. For example, Sichuan Haisco Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd have been approved to produce polyene phosphatidyl choline under the trade name of Yibisheng. Imported drugs mainly come from Sanofi (Beijing), Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Sanofi-Aventis Ukraine LLc and A.Nattermann & Cie.GmbH.

The growth of polyene phosphatidyl choline has accelerated since 2006, making it occupy an important proportion of the adjuvant drugs for liver disease. According to CRI's survey, the sales value of polyene phosphatidyl choline in sample hospitals rose from less than CNY 60 million in 2005 to over CNY 400 million in 2014 and CAGR during this period reached 25%. Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd had the largest market share of about 60% for sales value in 2014.

With the lifestyle changes brought about economic development, the incidence of liver disease in China has kept increasing. Therefore, the market size of polyene phosphatidyl choline is expected to continue to grow in the next few years in China.

Readers can get at least the following information from this report:

  • market size of polyene phosphatidyl choline in China
  • competitive landscape of polyene phosphatidyl choline in Chinese market
  • price of polyene phosphatidyl choline made by different enterprises in China
  • market outlook of polyene phosphatidyl choline in China

The author suggests the following groups of people purchase this report:

  • manufacturers of drugs for liver disease
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Polyene Phosphatidyl Choline

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Polyene Phosphatidyl Choline in China

  • 2.1. Patent and Approval Status of Polyene Phosphatidyl Choline in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Polyene Phosphatidyl Choline in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Polyene Phosphatidyl Choline in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Polyene Phosphatidyl Choline in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Polyene Phosphatidyl Choline in Chinese Hospitals in 2014

  • 6.1. Aventis Pharma S.p.A.(SP) (Trade Name: Essentiale Forte)
  • 6.2. Chengdu Tiantaishan Pharmaceutical Co., Ltd (Trade Name: Yibisheng)
  • 6.3. Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
  • 6.4. Shenzhen Sanofi Pasteur Biological Products Co., Ltd (Trade Name: Essentiale Forte)

7. Major Manufacturers of Polyene Phosphatidyl Choline in Chinese Market, 2010-2014

  • 7.1. Shenzhen Sanofi Pasteur Biological Products Co., Ltd
  • 7.2. Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd
  • 7.3. Chengdu Tiantaishan Pharmaceutical Co., Ltd
  • 7.4. Aventis Pharma S.p.A.

8. Market Outlook of Polyene Phosphatidyl Choline in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Polyene Phosphatidyl Choline in China
  • Chart Sales Status of Polyene Phosphatidyl Choline in China
  • Chart Sales Value of Polyene Phosphatidyl Choline in China, 2010-2014
  • Chart Sales Value of Polyene Phosphatidyl Choline in Some Regions in China, 2010-2014
  • Chart Sales Volume of Polyene Phosphatidyl Choline in China, 2010-2014
  • Chart Market Share of TOP3 Manufacturers of Polyene Phosphatidyl Choline for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Chengdu Tiantaishan in China, 2010-2014
  • Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Hangzhou Sanofi-Synthelabo Minsheng in China, 2010-2014
  • Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Aventis(SP) in China, 2010-2014
  • Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Made by Other Enterprises in China, 2010-2014
  • Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Injections in China, 2010-2014
  • Chart Sales Value and Market Share of Polyene Phosphatidyl Choline Capsules in China, 2010-2014
  • Chart Price of Polyene Phosphatidyl Choline Made by Aventis Pharma S.p.A.(SP) in Some Chinese Cities in 2014
  • Chart Price of Polyene Phosphatidyl Choline Made by Chengdu Tiantaishan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Polyene Phosphatidyl Choline Made by Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Polyene Phosphatidyl Choline Made by Shenzhen Sanofi Pasteur Biological Products Co., Ltd in Some Chinese Cities in 2014
Back to Top